Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Beta Drugs IPO is a fixed price issue of Rs 19.52 crores.
Beta Drugs IPO bidding started from September 29, 2017 and ended on October 4, 2017. The shares got listed on NSE SME on October 12, 2017.
Beta Drugs IPO price is ₹85 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹136,000.
Pantomath Capital Advisors Pvt Ltd is the book running lead manager of the Beta Drugs IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Beta Drugs IPO RHP for detailed information.
| IPO Date | September 29, 2017 to October 4, 2017 |
| Listing Date | October 12, 2017 |
| Face Value | ₹10 per share |
| Price | ₹85 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 2,296,000 shares (aggregating up to ₹19.52 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 6,335,500 |
| Share holding post issue | 8,649,500 |
Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹136,000 |
| Retail (Max) | 1 | 1600 | ₹136,000 |
| Lot Size Calculator | |||
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.
Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.
Company Strengths:
1. Focus on oncology segment. Manufacture over 50 products in this segment.
2. 18 product registrations in various countries. Company is in-process of making additional 12 applications for product registration in various countries.
Company intend to utilize the proceeds from this public issue towards the following objects:
1. Purchase of new plant and machinery and upgradation of our existing plant and machinery.
2. Civil Construction work at existing manufacturing unit.
3. To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme certificate.
4. Working Capital requirements.
5. General Corporate Purpose.
[Dilip Davda] Considering reasonable pricing and prospects of healthcare industry going forward, investment may be considered for short to long term. Read detail review...
The Beta Drugs IPO is subscribed times on October 4, 2017 5:00:00 PM. The public issue subscribed times in the retail category, times in the QIB category, and times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|
| Listing Date | October 12, 2017 |
| BSE Script Code | |
| NSE Symbol | BETA |
| ISIN | INE351Y01019 |
| Final Issue Price | ₹85 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹85.00 |
| ₹102.00 |
| ₹92.00 |
| ₹102.00 |
| ₹101.95 |
Beta Drugs Limited
Village Nandpur Baddi 17410
Phone: 01795-236196
Email: info@betadrugslimited.com
Website: http://betadrugslimited.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email:
Website: https://linkintime.co.in/initial_offer/public-issues.html
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
Beta Drugs IPO is a SME IPO of 2,296,000 equity shares of the face value of ₹10 aggregating up to ₹19.52 Crores. The issue is priced at ₹85 per share. The minimum order quantity is 1600 Shares.
The IPO opens on September 29, 2017, and closes on October 4, 2017.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
The Beta Drugs IPO opens on September 29, 2017 and closes on October 4, 2017.
Beta Drugs IPO lot size is 1600 Shares, and the minimum amount required is ₹136,000.
You can apply in Beta Drugs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Beta Drugs IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Beta Drugs IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
Top Contributor (300+ Posts, 200+ Likes)
IPO Mentor (800+ Posts, 1100+ Likes)
